TiA1 in advanced-stage classical Hodgkin's lymphoma: No prognostic impact for positive tumour cells or number of cytotoxic cells

Virchows Archiv

Volumn 445, Issue 4, 2004, Pages 344-346

  Camilleri Broët, Sophie ^a   Fermé, Christophe ^b   Berger, Françoise ^c   Lepage, Eric ^d   Bain, Serge ^a   Brière, Josette ^e   Marmey, Béatrice ^a   Gaulard, Philippe ^d   Audouin, Josée ^a  

^a Serv Ctrl d'Anat Cytologie P   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c CENTRE HOSPITALIER LYON SUD   (France)

^d HENRI MONDOR HOSPITAL   (France)

^e SAINT LOUIS HOSPITAL   (France)

Author keywords

Clinical pathology; Immunohistochemistry; Lymphoma

Indexed keywords

ANTIGEN; BIOLOGICAL MARKER; CD20 ANTIBODY; T CELL RESTRICTED INTRACELLULAR ANTIGEN 1; UNCLASSIFIED DRUG;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CANCER STAGING; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DIAGNOSTIC VALUE; FEMALE; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; TUMOR CELL;

ADULT; AGED; FEMALE; HODGKIN DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTES; MALE; MIDDLE AGED; POLY(A)-BINDING PROTEINS; PROGNOSIS; PROTEINS; REED-STERNBERG CELLS; RNA-BINDING PROTEINS;

EID: 8744289517     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-004-1057-6     Document Type: Article

References (8)

1. Anderson P, Nagler-Anderson C, O'Brien C et al (1990) A monoclonal antibody reactive with a 15-kDa cytoplasmic granule-associated protein defines a subpopulation of CD8+ T lymphocytes. J Immunol 144:574-582
2. Felgar RE, Macon WR, Kinney MC et al (1997) TIA-1 expression in lymphoid neoplasms. Identification of subsets with cytotoxic T lymphocyte or natural killer cell differentiation. Am J Pathol 150:1893-1900
3. Fermé C, Sebban C, Hennequin C et al (2000) Comparison of chemotherapy to radiotherapy as consolidation of complete or good partial response after six cycles of chemotherapy for patients with advanced Hodgkin's disease: results of the Groupe d'étude des Lymphomes de l'Adulte H89 trial. Blood 95:2246-2252
4. Kanavaros P, Vlychou M, Stefanaki K et al (1999) Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease. Anticancer Res 19:1209-1216
5. Krenacs L, Wellmann A, Sorbara L et al (1997) Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin's disease: evidence for distinct cellular origin. Blood 89:980-989
6. Mantel N (1966) Evaluation for survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163
7. Muschen M, Rajewsky K, Brauninger A et al (2000) Rare occurrence of classical Hodgkin's disease as a T cell lymphoma. J Exp Med 191:387-394
8. Oudejans JJ, Jiwa NM, Kummer JA et al (1997) Activated cytotoxic T cells as prognostic marker in Hodgkin's disease. Blood 89:1376-1382